Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

France

CHU de Besançon, Besançon

CHU Estain, Clermont-Ferrand

Hôpital Henri Mondor, Créteil

Centre Georges François Leclerc, Dijon

Centre Léon Bérard, Lyon

Hôpital Privé Jean Mermoz, Lyon

Hôpital Nord Franche Comté, Montbéliard

CHU Montpellier, Montpellier

Groupe hospitalier de la région de Mulhouse et Sud Alsace, Mulhouse

Centre Antoine Lacassagne, Nice

Hôpital Européen Georges Pompidou, Paris

Hôpital la Pitié-Salpétrière, Paris

Hôpital Saint antoine, Paris

Institut Mutualiste Montsouris, Paris

CHU de Reims - Hôpital Robert Debré, Reims

Hôpital FOCH, Suresnes